Fed Chair Kevin Warsh Wants to End the Era of Easy Money. These Stocks Could Thrive in the New Market Reality.

The article argues that a smaller Fed balance sheet under Kevin Warsh could be a tailwind for Berkshire Hathaway, JPMorgan Chase, and UnitedHealth Group. Berkshire's cash pile exceeds $397 billion, JPMorgan expects $103 billion in interest income this year, and UnitedHealth could earn more on float as rates rise. The piece is primarily a stock-picking commentary on quantitative tightening rather than new company-specific news.

Analysis

The first-order read is “higher rates help financials and balance-sheet-heavy incumbents,” but the second-order effect is a liquidity hierarchy shift: QT punishes duration, leverage, and marginal funding models while rewarding entities that can self-fund or reprice assets faster than liabilities. That makes BRK.B structurally interesting because it is effectively long short-term rates with an optionality overlay on dislocated equities; the real edge is not the carry, it is the future deployment power if risk assets cheapen.

JPM is better framed as a market-share thief than a pure rate beta. In a QT regime, smaller banks with sticky deposit franchises but weak securities books face a two-front squeeze: funding costs rise while mark-to-market pressure on legacy bond portfolios constrains balance-sheet flexibility. JPM’s scale lets it absorb deposit beta inflation and still widen spread capture, so the trade is less about absolute NII and more about relative deposit migration over the next 2-4 quarters.

UNH’s upside is more subtle and probably over-marketized. The float-income tailwind is real, but the bigger hidden benefit is that healthcare demand is the least discretionary revenue stream in the consumer universe, so any QT-induced slowdown is much less harmful to top-line stability than it is for cyclicals. The risk is that the market is already looking through some of this; if rates rise for the wrong reason—growth scare rather than policy normalization—UNH can lag because multiple compression overwhelms the float benefit.

The consensus may be underestimating the asymmetry between liquidity withdrawal and rate levels. QT can compress valuations faster than earnings can reprice, creating a window where BRK.B benefits most because it has dry powder to buy what forced sellers abandon. The main reversal catalyst is a fast pivot from QT to accommodation if funding markets seize up or regional-bank stress resurfaces; that would hit the whole basket within days, not months.

Key Decisions for Investors

• Long BRK.B vs short a basket of long-duration, cash-burning growth names for 3-6 months; the setup favors capital-rich bidders if QT widens equity dispersion. Risk: if policy quickly pivots dovish, the spread narrows sharply.
• Overweight JPM vs regional banks via KRE short or selective short exposure for 1-2 quarters; JPM should capture deposit migration and client share as smaller banks absorb funding stress. Risk/reward is best if rates grind higher rather than spike abruptly.
• Build a tactical long UNH only on weakness, with a 3-6 month horizon; treat it as a defensive compounder with float-income optionality, not a pure QT trade. Use tight risk controls if the market starts pricing recession, since multiple compression can dominate fundamentals.
• Consider a pair trade long BRK.B / short IWM for a liquidity-divergence view over the next 2-4 months; QT tends to hurt smaller, financing-dependent constituents more than mega-cap balance-sheet winners. Risk: a soft landing with easing financial conditions would reduce dispersion.
• If policy headlines intensify, use call spreads rather than outright longs in BRK.B and JPM to cap downside from a Fed reversal while preserving upside to a sustained QT regime.